Gait dynamics in mouse models of Parkinson's disease and Huntington's disease.
about
Speed-Dependent Modulation of the Locomotor Behavior in Adult Mice Reveals Attractor and Transitional GaitsNFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapyComprehensive functional characterization of murine infantile Batten disease including Parkinson-like behavior and dopaminergic markers.Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function.Inhibition of calpain increases LIS1 expression and partially rescues in vivo phenotypes in a mouse model of lissencephalyAutomated quantitative gait analysis in animal models of movement disorders.Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease.Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors.Bone marrow transplantation in dysferlin-deficient mice results in a mild functional improvement.A translational approach to capture gait signatures of neurological disorders in mice and humans.Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration.Gait analysis in normal and spinal contused mice using the TreadScan system.Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease.Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis.Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotectionComplex pattern of interaction between in utero hypoxia-ischemia and intra-amniotic inflammation disrupts brain development and motor function.Motor and cognitive deficits in aged tau knockout mice in two background strains.A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions.Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson's disease.Gait analysis in a Mecp2 knockout mouse model of Rett syndrome reveals early-onset and progressive motor deficitsLack of tryptophan hydroxylase-1 in mice results in gait abnormalities.Chronic L-DOPA induces hyperactivity, normalization of gait and dyskinetic behavior in MitoPark miceCurcumin Treatment Improves Motor Behavior in α-Synuclein Transgenic MiceChanges in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical ImplicationsPostnatal Erythropoietin Mitigates Impaired Cerebral Cortical Development Following Subplate Loss from Prenatal Hypoxia-Ischemia.A novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson's disease.Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice.Repeated Closed Head Injury in Mice Results in Sustained Motor and Memory Deficits and Chronic Cellular Changes.Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.A chronic mouse model of Parkinson's disease has a reduced gait pattern certainty.Gait analysis in a murine model of collagen-induced arthritis.The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injuryA dystonia-like movement disorder with brain and spinal neuronal defects is caused by mutation of the mouse laminin β1 subunit, Lamb1.The need for speed in rodent locomotion analyses.MsrA knockout mouse exhibits abnormal behavior and brain dopamine levelsResponse to ethanol induced ataxia between C57BL/6J and 129X1/SvJ mouse strains using a treadmill based assay.Neurological Dysfunction in Early Maturity of a Model for Niemann-Pick C1 Carrier Status.Age, experience and genetic background influence treadmill walking in mice.
P2860
Q27313443-22364FF4-EAF7-4255-8885-D72C16E35525Q28586033-21A0C4CC-F6C6-4876-8D56-6546BC352A86Q30405389-F500613D-C18B-462F-A0C4-F3FDE9EAC9EDQ30481530-EE88DB0F-673D-4F26-8FB7-0A4A1E5FF4F8Q30490856-7999636F-B39E-4C1A-BC39-FCA851EF9EA6Q30496179-F2A6BC25-D41E-4102-AF44-0E2F09B30DCAQ30512976-7B6F3AE0-5528-4A37-8231-3495E1D30160Q30516504-37D40473-2587-400C-9356-9581331AADC0Q30524899-0AFCA93B-B0B3-4220-AAD6-D7E4772910ABQ30552419-5977F9F3-2EED-4370-9959-C289E098C29CQ30855500-77F07820-8AD4-46DC-ADF4-2F5B2EB60B49Q33401101-3E93A6E2-F826-425D-9DE5-49A73D690F18Q33618985-B58397CF-041B-4417-950E-9A092941BA16Q33835301-794CFC9A-6F5B-4C16-B106-EC9BC48A9057Q33911605-B6CB6042-FC6A-422F-9B54-099764E792A8Q33916838-78DA24D8-B668-486D-8E8F-E4D77626B8F8Q34026944-72C972FD-DB7A-40F5-86BF-9781A4C9B3C2Q34077327-F619A156-3900-46A6-993D-E7BEED645EA2Q34094065-7A8FE237-660A-4D24-8572-455C0A1BEBA0Q34181738-C0EB60CB-6032-4271-A98F-ACAB86FC4502Q34476803-8DB07BE8-81EC-4FEB-AA07-D0A2C925A740Q34506454-554F6F19-443B-4C2D-B91C-5E9FBA296228Q34630258-60BABC88-5406-45AD-85F1-EB46F2063C8FQ35509519-ACC6BE0C-F505-4EF9-862F-3626FF762272Q35650069-82448334-B1A1-4E0B-AD4D-33857F6C7743Q35952063-8C3FD564-ACEC-4026-A74C-0E78ED03BFA9Q35956626-F3C09D6C-6CCF-4B3A-AB8F-1AE47DFE05F3Q36020733-FD4065B5-D878-4E04-B4BF-87E2AD612560Q36021445-14CB776A-31DF-4253-8703-A5697F04F98FQ36079903-83710FE0-87BF-412C-9E4F-C6133AE273B1Q36200063-CB106549-AD00-4BF8-B255-A48B19338D2BQ36248652-06B7F8B3-8975-4618-B3C1-4D656D2AB213Q36465487-5D00E785-D6F8-4154-BB7F-29DA329F4CF5Q36476846-2BB34256-C686-430B-9A93-9C03B24838E7Q36568475-DDBE2BC7-95B5-45B4-9364-060519F7AA4DQ36592396-99BAAAE8-9FD3-4F0E-A05C-1E22D38C1FADQ36838161-1E3B533C-BF80-466F-AB4F-DDF579DDE233Q36988393-D6963465-B57F-4F3A-80D4-9EFD39509792Q37136442-22AA8190-9F4E-426F-8B93-D94B413F475AQ37382566-17067C51-9F5B-4BF5-8E37-F2DAC9E275FB
P2860
Gait dynamics in mouse models of Parkinson's disease and Huntington's disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Gait dynamics in mouse models of Parkinson's disease and Huntington's disease
@nl
Gait dynamics in mouse models of Parkinson's disease and Huntington's disease.
@ast
Gait dynamics in mouse models of Parkinson's disease and Huntington's disease.
@en
type
label
Gait dynamics in mouse models of Parkinson's disease and Huntington's disease
@nl
Gait dynamics in mouse models of Parkinson's disease and Huntington's disease.
@ast
Gait dynamics in mouse models of Parkinson's disease and Huntington's disease.
@en
prefLabel
Gait dynamics in mouse models of Parkinson's disease and Huntington's disease
@nl
Gait dynamics in mouse models of Parkinson's disease and Huntington's disease.
@ast
Gait dynamics in mouse models of Parkinson's disease and Huntington's disease.
@en
P2093
P2860
P3181
P356
P1476
Gait dynamics in mouse models of Parkinson's disease and Huntington's disease.
@en
P2093
Ivo Amende
James P Morgan
Scott Glazier
Scott McCue
Thomas G Hampton
P2860
P2888
P3181
P356
10.1186/1743-0003-2-20
P407
P577
2005-07-25T00:00:00Z
P5875
P6179
1000637145